Farmak reinvests 95% of its profits in the development.
“We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a very large amount of money, but I have no intention to sell them. Basically, I am a rather wealthy person, but I have no special wealth. And I do not need it – I do not like a luxurious life. When I am abroad, I prefer to go and buy food at the market than dine at a fancy restaurant,” said Filya Zhebrovska, Chairman of the Supervisory Board of JSC Farmak in the interview with Focus.
As Filya Zhebrovska explains, the Company now goes through the transition period that will last for another two or three years. “In 2017, before retiring from business, I worked a lot on business processes, and then I invited Slovakian expatriate manager Augustin Dubnička to manage the Company, as I wanted to make sure that the built processes were clear for people from the outside. He worked for nine months and we experienced no catastrophe. After that, I entrusted control to Volodymyr Kostiuk, and since then I have not interfered with the operational activities. All top managers of the Company, with whom we created Farmak, joined me in the Supervisory Board. We have to afford an opportunity to the next generation to prove themselves,” she said.
It is worth noting that Farmak plans to invest approximately UAH 1.2 billion in the development in 2020.
Taking into consideration the increased public interest in medical science, Liga.net and Farmak created a joint project that gives an idea of the current situation (and the situation over past 20 years) in the world medicine. 20 medical innovations which have been the most important in the 21st century were selected. The choice was […]
Farmak reported 2019 financial results. The performance of the Company remains at a consistently high level. According to IFRS-compliant financial statements, the amount of money spent on capital investment in 2019 was UAH 714 million, which is 14.5% more than at the end of 2018. The revenue of Farmak reached UAH 6.542 billion, net profit […]
Today, Kyiv City Clinical Hospital No. 9 and Kyiv City Children’s Clinical Hospital No. 1, where coronavirus patients are treated, have been equipped with CARDIOVIT AT-1 G2 ECG machine, DEFIGARD 4000 Defibrillator/Monitor, and IM-80 (2.0) patient monitor due to the assistance of the Zhebrivski Family Charitable Foundation. 13 medical specialists will be trai...